[go: up one dir, main page]

AU4625196A - Ultrasensitive process for assaying cardiac troponin I - Google Patents

Ultrasensitive process for assaying cardiac troponin I

Info

Publication number
AU4625196A
AU4625196A AU46251/96A AU4625196A AU4625196A AU 4625196 A AU4625196 A AU 4625196A AU 46251/96 A AU46251/96 A AU 46251/96A AU 4625196 A AU4625196 A AU 4625196A AU 4625196 A AU4625196 A AU 4625196A
Authority
AU
Australia
Prior art keywords
ultrasensitive
cardiac troponin
assaying
assaying cardiac
troponin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU46251/96A
Other versions
AU703944B2 (en
Inventor
Charles Calzolari
Odile Flecheux
Bernard Pau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Bio Rad Innovations SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Innovations SAS filed Critical Bio Rad Innovations SAS
Publication of AU4625196A publication Critical patent/AU4625196A/en
Application granted granted Critical
Publication of AU703944B2 publication Critical patent/AU703944B2/en
Assigned to BIO-RAD PASTEUR reassignment BIO-RAD PASTEUR Request to Amend Deed and Register Assignors: PASTEUR SANOFI DIAGNOSTICS
Assigned to BIO-RAD INNOVATIONS reassignment BIO-RAD INNOVATIONS Request to Amend Deed and Register Assignors: BIO-RAD PASTEUR
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The present invention relates to a ultrasensitive process for assaying cardiac troponine I by means of chemiluminescence.
AU46251/96A 1995-01-19 1996-01-19 Ultrasensitive process for assaying cardiac troponin I Ceased AU703944B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9500597 1995-01-19
FR9500597A FR2729759A1 (en) 1995-01-19 1995-01-19 ULTRASENSITIVE DOSING METHOD FOR THE CARDIAC TROPONIN I
PCT/FR1996/000095 WO1996022535A1 (en) 1995-01-19 1996-01-19 Ultrasensitive process for assaying cardiac troponine i

Publications (2)

Publication Number Publication Date
AU4625196A true AU4625196A (en) 1996-08-07
AU703944B2 AU703944B2 (en) 1999-04-01

Family

ID=9475293

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46251/96A Ceased AU703944B2 (en) 1995-01-19 1996-01-19 Ultrasensitive process for assaying cardiac troponin I

Country Status (13)

Country Link
EP (1) EP0804736B1 (en)
JP (1) JP3558643B2 (en)
KR (1) KR100237239B1 (en)
CN (1) CN1105306C (en)
AT (1) ATE178410T1 (en)
AU (1) AU703944B2 (en)
BR (1) BR9607164A (en)
DE (1) DE69601922T2 (en)
DK (1) DK0804736T3 (en)
ES (1) ES2131929T3 (en)
FR (1) FR2729759A1 (en)
GR (1) GR3030113T3 (en)
WO (1) WO1996022535A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718767B2 (en) * 1995-06-07 2000-04-20 Bioveris Corporation Electrochemiluminescent enzyme immunoassay
JP4545685B2 (en) * 2003-04-16 2010-09-15 小野薬品工業株式会社 Screening method for therapeutic substance for heart disease and pharmaceutical composition for treating cardiac disease
CN101105497B (en) * 2006-07-13 2011-10-19 上海凯创生物技术有限公司 Cardiac muscle troponin I detection reagent kit and its preparation method
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
CN102183657B (en) * 2011-02-24 2014-02-05 南京基蛋生物科技有限公司 Method for greatly improving chemiluminescence magnetic enzyme immunization sensitivity by depending on polystyrene nanoparticles
WO2013094080A1 (en) * 2011-12-20 2013-06-27 パナソニック株式会社 Recombinant protein capable of specifically and rapidly binding to troponin-i originated from human cardiac muscles
US8603760B2 (en) 2011-12-20 2013-12-10 Panasonic Corporation Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
JPWO2013099043A1 (en) * 2011-12-26 2015-04-30 パナソニックヘルスケア株式会社 Recombinant protein capable of binding specifically and rapidly to human cardiac muscle-derived troponin I
CN102735848A (en) * 2012-07-05 2012-10-17 北京源德生物医学工程有限公司 Enzymatic chemiluminescence immunodetection method and reagent kit for human troponin I
JP2017530356A (en) 2014-09-26 2017-10-12 ソマロジック, インコーポレイテッドSomaLogic, Inc. Prediction and use of cardiovascular risk events
CN105132383A (en) * 2015-07-25 2015-12-09 大庆麦伯康生物技术有限公司 Hybridomas capable of producing anti-cTnI (cardiac troponini I) monoclonal antibodies
JP6651794B2 (en) * 2015-11-05 2020-02-19 富士レビオ株式会社 Cardiac troponin I measuring reagent and method
EP3438666B1 (en) 2016-03-31 2020-10-14 ABSOLOGY Co., Ltd Method for highly sensitive biomarker quantification using photo-oxidation amplification
CN110031635A (en) * 2019-05-16 2019-07-19 杭州普鲁米生物科技有限公司 Flash type homogeneous chemistry luminescence technology detects cardiac muscle troponin I/T method
CN112014573B (en) * 2020-08-25 2023-08-08 武汉生之源生物科技股份有限公司 Preparation method of high-sensitivity assay kit for troponin I in human whole blood sample and kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3463395D1 (en) * 1983-02-11 1987-06-04 Nat Res Dev Enhanced luminescent or luminometric assay
US4931223A (en) * 1986-07-24 1990-06-05 Tropix, Inc. Methods of using chemiluminescent 1,2-dioxetanes
US5336596A (en) * 1991-12-23 1994-08-09 Tropix, Inc. Membrane for chemiluminescent blotting applications
DE69420556T2 (en) * 1993-05-17 2000-03-23 Fortron Bioscience, Inc. ASSAY FOR TROPONIN I FROM THE HEART MUSCLE

Also Published As

Publication number Publication date
DE69601922T2 (en) 1999-10-07
KR100237239B1 (en) 2000-01-15
JPH10512672A (en) 1998-12-02
MX9705411A (en) 1997-11-29
AU703944B2 (en) 1999-04-01
ES2131929T3 (en) 1999-08-01
JP3558643B2 (en) 2004-08-25
BR9607164A (en) 1997-11-11
WO1996022535A1 (en) 1996-07-25
FR2729759A1 (en) 1996-07-26
CN1105306C (en) 2003-04-09
DE69601922D1 (en) 1999-05-06
ATE178410T1 (en) 1999-04-15
EP0804736B1 (en) 1999-03-31
EP0804736A1 (en) 1997-11-05
DK0804736T3 (en) 1999-10-18
GR3030113T3 (en) 1999-07-30
KR19980701608A (en) 1998-06-25
CN1176002A (en) 1998-03-11

Similar Documents

Publication Publication Date Title
AU4625196A (en) Ultrasensitive process for assaying cardiac troponin I
BG102016A (en) Method for the diagnostics of schizophrenia
AU7062496A (en) Process for the production of Bis(silyalkyl)-disulfanes
AU2959995A (en) Stereochemical wortmannin derivatives
AU4657396A (en) Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
UA5972A1 (en) Process for the preparation of substituted 2-mercaptoimidazoles
UA6044A1 (en) Method for producing methylene derivatives of androsta-1,4-dien-3,17-dion
HUP9900897A3 (en) Process for the production of cesium compounds
MX9704893A (en) Lewis x derivative and process for producing the same.
ATE266030T1 (en) 1,4,7,10-TETRAAZABICYCLO(8.2.2)TETRADECAN-2-ONE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE FOR THE PRODUCTION OF TETRAAZAMACROCYCLES
AU547636B2 (en) Process for enzymatic preparation of l-2-amino-4 methyl- phosphino-butyric acid
ES8707731A1 (en) A PROCEDURE FOR THE PREPARATION OF OXINDOL DERIVATIVES
AU8124494A (en) Conversion of bisnoralcohol to bisnoraldehyde
ES2125463T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF N-ACETYL NEURAMINIC ACID.
AU4548496A (en) Method for assay of analyte by adjustment of chemiluminescence
MX9706744A (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives.
EA199900740A1 (en) METHOD OF OBTAINING EPROSARTAN (OPTIONS)
EP0614853A3 (en) Method for the production of beta-zeloite.
AU7214298A (en) Process for making a butylthio-isoquinoline and intermediates therefor
MY118813A (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
MX9504316A (en) Method for making a substituted benzene compound.
CA2210166A1 (en) Ultrasensitive process for assaying cardiac troponine i
AU5665796A (en) Process for making heterocyclic compounds
MX9603450A (en) Process for the obtention of substituted aminotriazolines.
ES8400401A1 (en) Process for producing substituted pyrroles.

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: BIO-RAD PASTEUR

Free format text: FORMER NAME WAS: PASTEUR SANOFI DIAGNOSTICS